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Abstract
Human body height is a complex genetic trait with high heritability. We performed an association study of 17 candidate
genes for height in the Uppsala Longitudinal Study of Adult Men (ULSAM) that consists of 1153 elderly men of age 70 born
in the central region of Sweden. First we genotyped a panel of 137 single nucleotide polymorphism (SNPs) evenly
distributed across the candidate genes in the ULSAM cohort. We identified 4 SNPs in the estrogen receptor gene (ESR1) on
chromosome 6q25.1 with suggestive signals of association (p,0.05) with standing body height. This result was followed up
by genotyping the same 25 SNPs in the ESR1 gene as in ULSAM in a second population cohort, the Prospective Investigation
of the Vasculature in Uppsala Seniors (PIVUS) cohort that consist of 507 males and 509 females of age 70 from the same
geographical region as ULSAM. One SNP, rs2179922 located in intron 4 of ESR1 showed and association signal (p=0.0056)
in the male samples from the PIVUS cohort. Homozygote carriers of the G-allele of the SNP rs2179922 were on average
0.90 cm taller than individuals with the two other genotypes at this SNP in the ULSAM cohort and 2.3 cm taller in the PIVUS
cohort. No association was observed for the females in the PIVUS cohort.
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Introduction
Most human traits and diseases are complex, involving multiple
genes and environmental factors. Human body height and its
variation between individuals is a typical complex trait with high
heritability [1]. Several genome-wide linkage studies on height
have been performed in recent years, and these studies suggest
multiple genomic regions harboring genes affecting body height
[2–9]. Loci with suggested linkage with body height have been
reported on all chromosomes except chromosomes 10, 16 and 19,
but only a subset of these loci have been identified in multiple
studies. This lack of reproducible findings could be due to a large
number of genes with small individual additive effects on height.
This notion is corroborated by a recent study that studied genome
partitioning of genetic variation using linkage data from over ten
thousand sib pairs and found that most chromosomes could
harbor loci that affect human height[10]. Given that most
population-based studies have collected information on anthropo-
metric measures, including height, there is a surprising lack of
findings of genes that are associated with normal body height in
populations. However, a recent genome-wide association study
identified a common variant of the high mobility group-A2 gene
(HMGA2) that shows convincing evidence of association with
height, and replicated this finding in several population
cohorts[11]. In the current study we analyzed the population-
based Uppsala Longitudinal Study of Adult Men (ULSAM) cohort
for the association of single nucleotide polymorphisms (SNPs) in 17
candidate genes with height (Table 1), and followed up our
findings of suggestive association signals in the estrogen receptor
gene (ESR1) in a second very similar population cohort, the
Prospective Investigation of the Vasculature in Uppsala Seniors
(PIVUS) cohort.
Materials and Methods
Study cohorts
ULSAM is an on-going, longitudinal, epidemiologic study on
cardiovascular diseases in all men born between 1920 and 1924 in
Uppsala County, Sweden (www.pubcare.uu.se/ULSAM) [12]. The
men were investigated at ages 50, 60, 70, 77 and 82. The DNA
samples analyzed in the present study (n=1153) were collected
when the participants had reached 70 years of age and standing
body height used in the current study was measured at the same
time. PIVUS is also a longitudinal population-based study focused
on vascular function and body composition (www.medsci.uu.se/
pivus/pivus.htm). The PIVUS cohort consists of 1016 participants
with507males and 509 females of age 70 born in1931 orlater[13].
Measurements of standing body height were taken at the first
sample collection at age 70. Height was measured to the nearest cm
in both cohorts. Both population cohorts are from the Uppsala
region in Central Sweden. The studies were approved by the Ethics
Committee of the Faculty of Medicine at Uppsala University and
informed consent was obtained from all participants.
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A panel of 174 single nucleotide polymorphisms (SNP) located
in 17 potential candidate genes for height were selected from
dbSNP (www.ncbi.nlm.nih.gov/projects/SNP/) for genotyping in
the DNA samples from the ULSAM cohorts. The principle for
SNP selection was to cover the genes, including exons and introns
using SNPs with minor allele frequencies .0.05 at an even spacing
of 1.5 kb to 12.5 kb, depending in the size of the genes. In
addition, an Illumina design score of 0.5 was used as the lower
limit for acceptance of a SNP for genotyping. The 174 selected
SNPs (Supplementary Table S1) were genotyped in the ULSAM
cohort using the GoldenGate assay [14] and the Illumina
BeadArray system (Illumina, San Diego, CA, USA). Genotypes
were successfully called for 137 of the selected SNPs. Out of the 37
SNPs that were failed, twenty five were not polymorphic, ten SNPs
had sample call rates below 90% and finally two SNPs for which
the genotype distribution deviated from Hardy-Weinberg equilib-
rium (p.0.05) were excluded from further analysis. The average
call rate for the SNPs that passed quality control was 96.3% and
the reproducibility of genotyping was 99.98% according duplicate
determination of 4% of the genotypes. The rs-numbers and
nucleotide positions for the successfully genotyped SNPs are
provided in the Appendix. An additional panel of 33 tag-SNPs in
the ESR1 gene were selected using the Haploview software [15] by
considering the variation captured by the 25 successfully
genotyped SNPs in the ESR1 gene. In addition to the 33 tag-
SNPs, three SNPs successfully genotyped with the GoldenGate
assay were included for testing accuracy between genotyping
methods. The second round of ESR1 genotyping the ULSAM
cohort was performed using the SNPstream
TM genotyping system
(Beckman Coulter, Fullerton, CA, USA) [16]. Of the 36 SNPs, 24
passed quality control. The average call rate was 92% and the
accuracy of the genotyping was 99.7% based on comparison of the
data from the 3 SNPs genotyped by both systems. In total 47 SNPs
in the ESR1 gene were successfully genotyped in the ULSAM
cohort (Table 2). Twenty five SNPs in the ERS1 gene that were
genotyped in the ULSAM cohort were also genotyped in the
PIVUS cohort using the GoldenGate Assay. All SNPs were
successfully genotyped with an average call rate of 99.5% and
reproducibility of 99.8% based on duplication of 2% of the
genotypes.
Statistical analysis
The statistical analysis was performed using the free statistical
software environment ‘‘R’’ [17]. Analysis of variance (ANOVA)
was performed to test for association between SNPs and height.
Replicated nominally significant results from ANOVA (p,0.05)
were tested using a two sample t-test on body height according to
genotype distribution (Figure 1). In the PIVUS cohort, males and
females were analyzed separately because of known differences in
heritability of body height [1]. The Haploview software ‘‘Tagger’’
was used for SNP selection and to estimate the amount of SNP
variation captured by the panel of SNPs.
Results
The initial screening phase of our study included 17 candidate
genes for height. Three main criteria were used for selecting the
genes for study. The BRD8, ESR1, GHRH, MMP16, MMP19,
and PHACTR2 genes were primarily selected based on their
position in a genomic region identified by a genome-wide linkage
study for height, in combination with a possible functional role in
growth and bone development. The COMP, DRD2, EGR3,
GH1, GHR, GHRHR and GRB2 genes were selected solely
according to their known biological functions related to growth
and bone development. The FGF13, FGFR3, IRS4 and SOX3
are genes reported to be involved in rare syndromes characterized
by short stature (Table 1). A panel of SNPs that were evenly
distributed across these genes was genotyped in DNA samples
from 1153 males of age 70 from the population-based ULSAM
cohort of elderly men. Using ANOVA to analyze the SNPs for
association with standing body height, we observed 4 SNPs
(rs2234693, rs2347867, rs6927072, rs2179922) with nominally
Table 1. Genes and number of SNPs analyzed for association with body height
Gene symbol Gene name Chromosome position Number of SNPs analyzed
BRD8 bromodomain containing 8 5q31.2 7
COMP cartilage oligomeric matrix protein 19p13.11 3
DRD2 dopamine receptor D2 11q23.2 8
EGR3 early growth response 3 8p21.3 5
ESR1 estrogen receptor 1 6q25.1 23
FGF13 fibroblast growth factor 13 Xq26.3 7
FGFR3 fibroblast growth factor receptor 3 4p16.3 3
GH1 growth hormone 1 17q23.3 3
GHR growth hormone receptor 5p12 20
GHRH growth hormone releasing hormone 20q11.23 5
GHRHR growth hormone releasing hormone receptor 7p14.3 6
GRB2 growth factor receptor-bound protein 2 17q25.1 7
IRS4 insulin receptor substrate 4 Xq22.3 2
MMP16 matrix metallopeptidase 16 (membrane-inserted) 8q21.3 21
MMP19 matrix metallopeptidase 19 12q13.2 6
PHACTR2 phosphatase and actin regulator 2 6q24.2 8
SOX3 SRY (sex determining region Y)-box 3 Xq27.1 3
doi:10.1371/journal.pone.0001807.t001
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ULSAM PIVUS
SNP
SNP-allele major/
minor MAF
1 p-value MAF p-value
Genotyping
method
2
rs10484922 C/T 0.11 0.93 - - 3
rs3853248 T/C 0.13 0.62 0.15 0.57 1,2
rs11155813 T/C 0.12 0.47 0.13 0.86 1,2
rs827423 A/G 0.48 0.014 - - 3
rs9322331 C/T 0.31 0.040 - - 3
rs2234693 T/C 0.43 0.044 0.46 0.95 1,2,3
rs1709183 T/C 0.28 0.54 0.27 0.35 1,2
rs11155819 T/C 0.33 0.15 - - 3
rs9340835 G/A 0.33 0.092 0.34 0.28 1,2
rs9322335 C/T 0.25 0.026 - - 3
rs1913474 G/A 0.23 0.37 0.22 0.71 1,2,3
rs2347867 A/G 0.33 0.037 0.32 0.44 1,2
rs6557171 C/T 0.30 0.12 0.29 0.22 1,2
rs12204714 T/C 0.33 0.068 - - 3
rs988328 T/C 0.14 0.24 - - 3
rs6927072 G/T 0.33 0.023 0.31 0.18 1,2
rs1801132 C/G 0.23 0.077 0.20 0.46 1,2
rs3020314 T/C 0.33 0.29 - - 3
rs3020377 A/G 0.36 0.11 0.31 0.11 1,2
rs3020393 A/G 0.17 0.17 - - 3
rs3020394 A/G 0.32 0.21 - - 3
rs3003925 A/G 0.21 0.35 - - 3
rs6557177 T/C 0.15 0.50 - - 3
rs985694 C/T 0.19 0.10 0.17 0.016 1,2
rs1884049 C/T 0.19 0.023 - - 3
rs2179922 G/A 0.11 0.020 0.10 0.0056 1,2
rs2982683 C/T 0.30 0.26 - - 3
rs3020407 A/G 0.34 0.10 - - 3
rs7754762 T/A 0.13 0.24 0.13 0.30 1
rs722208 A/G 0.31 0.47 0.31 0.33 1,2
rs2207232 T/C 0.13 0.22 0.13 0.33 1,2,3
rs3020422 G/A 0.37 0.48 0.40 0.44 1,2
rs3020353 C/A - - 0.40 0.44 2
rs9371573 C/A 0.37 0.35 - - 1
rs3020368 C/T 0.090 1.0 0.092 0.71 1,2
rs3778082 G/A 0.14 0.18 0.14 0.22 1,2
rs11965894 C/T 0.090 0.38 - - 3
rs7766585 T/G 0.15 0.076 0.12 0.20 1,2
rs9322355 C/T 0.10 0.18 0.11 0.28 1,2
rs3020382 T/C 0.18 0.58 - - 3
rs2813544 A/G 0.20 0.87 0.20 0.80 1,2
rs7450824 T/C 0.26 0.39 - - 1
rs2747653 T/C 0.20 0.47 - - 3
rs2813563 C/T 0.21 0.48 - - 3
rs725467 C/T 0.20 0.78 - - 1,2
rs2673790 A/G 0.29 0.33 - - 3
rs2252837 C/T 0.29 0.64 - - 3
SNPs are listed 59-39 from top to bottom of this table.
1Minor allele frequency.
21: GoldenGate
TM assay ULSAM panel, 2: GoldenGate
TM assay PIVUS panel, 3: SNPstream
TM system.
doi:10.1371/journal.pone.0001807.t002
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gene (ESR1) (Table 2). We did not apply correction for multiple
testing in this exploratory screen because of the availability of the
highly similar PIVUS cohort for replication. Based on the
suggestive findings in the ULSAM cohort, we selected the ESR1
gene for further study. By analyzing the data from the same set of
25 SNPs in the ESR1 gene for association with height in the
PIVUS cohort, we observed a clear association signal from the
SNP rs2179922 located in intron 4 of ESR1 in males from the
PIVUS cohort (p=0.0056) (Table 2). No association was observed
for the females from the PIVUS cohort. Homozygote carriers of
the G-allele were on average 0.90 cm taller than individuals with
the two other genotypes at this SNP in the ULSAM cohort
(Figure 1), and 2.3 cm taller in the PIVUS cohort. To complement
the variation of the ESR1 gene captured by the original set of 25
SNPs, we genotyped an additional panel of 21 tag-SNPs in the
ULSAM cohort. Three of them yielded associations signals with
nominal p-values,0.05 (Table 2), but addition of these 21 SNPs
did not strengthen our previous findings in the ULSAM cohort
notably. Figure 2 shows the positions of the 47 SNPs in the ESR1
gene that were genotyped in the ULSAM cohort and the linkage
disequilibrium values between the SNPs. These SNPs capture 73%
of the common SNP variation of ESR1 (MAF$0.05) in the
European sample from the HapMap project.
Discussion
In our study we screened potential candidate genes for body
height and identified and replicated association of the SNP
rs2179922 in intron 4 of the ESR1 gene with standing body height
in elderly males from two distinct, but highly similar Swedish
population cohorts. The ESR1 gene is located at chromosome
Figure 1. Analysis of body height according to genotype of the
SNP rs2179922 in the ULSAM and PIVUS cohorts. The number of
observations (n) is shown below each genotype group and the error
bars indicate the standard deviation in cm in each group. Mean body
height in the ULSAM cohort was 175.166.0 cm for GG genotype group
and 174.266.8 cm for the AG+AA group. Mean body height in the
PIVUS cohort was 172.266.3 cm for GG genotype group and
173.966.8 cm for the AG+AA group.
doi:10.1371/journal.pone.0001807.g001
Figure 2. Schematic illustration of the estrogen receptor gene (ESR1) and its linkage disequilibrium structure. The line in the top part
of the figure illustrates the ESR1 gene with the exons marked with horizontal lines. The lower part of the figure shows the positions of the single
nucleotide polymorphisms (SNPs) in ESR1 genotyped in the ULSAM cohort with pair-wise linkage disequilibrium (r
2) values. The SNPs with nominal p-
values,0.05 in the ULSAM cohort are marked with stars, and the SNP rs2179922 located in intron 4 of ESR1 with p=0.0056 in the PIVUS cohort is
marked by a large star.
doi:10.1371/journal.pone.0001807.g002
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two large genome-wide linkage studies [2,18]. Estrogen plays an
important role in the regulation of bone maturation and in the
closure of epiphyseal plates in growing bones in both females and
males [19]. The role for estrogen in skeletal development and
growth in females has been well established since the 50s. More
recently it was recognized that estrogen also affects bone
development and body height in males [20]. This notion was
pioneered by a case report of a male with complete estrogen
resistance due to homozygous mutations in the ESR1 gene [21].
This patient showed incomplete epiphyseal closure and a history of
continued growth into adulthood resulting in a standing body
height of 204 cm. Based on this strong effect of rare recessive
mutations in the ESR1 on body height, it is conceivable that other,
more common variants of ESR1 with smaller effects could affect
body height on the population level. Given the importance of
estrogen for adult height in both genders, and two previous reports
that suggested associations between SNPs in the ESR1 gene and
adult body height in females [22,23], it was surprising that we did
not detect an association between the ESR1 and height in the
females from the PIVUS cohort. In previous studies a haplotype of
ESR1 defined by the SNP rs2234693 was associated with height in
females and young boys [23,24]. In our study we also genotyped
the SNP rs2234693, and it showed a suggestive association with
height in the ULSAM cohort (p=0.04), but this finding did not
replicate in males or females from the PIVUS cohort. In our study
samples, the SNPs rs2234693 is not in LD (r
2=0) with the SNP
rs2179922, which showed association with height in males from
both the ULSAM and PIVUS cohorts. The most plausible
explanation for the lack of association between ESR1 and height in
females in our study is that we did not have sufficient statistical
power to detect weak genetic effects. The effects on body height
between different variants of the ESR1 gene may also differ
between males and females. The effect on body height of the G-
allele of the SNP rs2179922 in ESR1 that we observed in males
from the ULSAM and PIVUS cohorts is comparable to the effect
of the SNP rs1042725 in the HMGA2 gene in adult males in
multiple cohorts from the UK and Sweden [11].
In conclusion, the results from our study on informative
common SNPs in 17 strong candidate genes for height are in
line with previous studies, which indicate that a large number of
genetic variants with small individual effects contribute to the high
heritability of human body height. Our results suggest that ESR1 is
one of these genes, but the power of our study does not allow us to
exclude small effects on height by the other candidate genes
analyzed. To identify the actual functional variants in the ESR1
gene that affect height will require re-sequencing of the genes to
identify possible rare variants, and functional studies on the
molecular level, as well as very large population-based studies on
the interactions between genes and with factors from the
environment.
Supporting Information
Table S1 Gene, chromosome and nucleotide position for the
SNPs analyzed in the ULSAM Illumina panel.
Found at: doi:10.1371/journal.pone.0001807.s001 (0.03 MB
XLS)
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